Literature DB >> 23770225

Size effect of amphiphilic poly(γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo.

Fumiaki Shima1, Tomofumi Uto, Takami Akagi, Masanori Baba, Mitsuru Akashi.   

Abstract

We prepared size-regulated nanoparticles (NPs) composed of amphiphilic poly(γ-glutamic acid) (γ-PGA). In this study, 40, 100 and 200 nm γ-PGA-graft-l-phenylalanine ethylester (γ-PGA-Phe) NPs were employed. The size of NPs significantly influenced the uptake and activation behaviors of antigen-presenting cells (APCs). When 40 nm γ-PGA-Phe NPs were applied to these cells in vitro, they were highly activated compared with 100 and 200 nm NPs, while cellular uptake was size dependent. The size of the γ-PGA-Phe NPs also significantly affected their migration to the lymph nodes and uptake behavior of NPs by dendritic cells (DCs) in vivo. The 40 nm γ-PGA-Phe NPs migrated more rapidly to the lymph nodes and were taken up by a greater number of DCs compared with 100 and 200 nm NPs. On the other hand, when the amount of γ-PGA-Phe NPs taken up per DC was evaluated, it was higher for 100 and 200 nm NPs than for 40 nm NPs, which suggests that the larger γ-PGA-Phe NPs can deliver a large amount of antigen to a single DC compared with smaller NPs. Furthermore, when examined the maturation of DCs in lymph nodes, 40 nm γ-PGA-Phe NPs efficiently stimulated DCs. These results suggest that the activation, uptake behavior by APCs, migration to lymph nodes, and DC maturation can be controlled by the size of γ-PGA-Phe NPs.
Copyright © 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dendritic cells; Lymph nodes; Nanoparticles; Particle size; Vaccine

Mesh:

Substances:

Year:  2013        PMID: 23770225     DOI: 10.1016/j.actbio.2013.06.010

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  12 in total

1.  Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery.

Authors:  Susan N Thomas; Alex Schudel
Journal:  Curr Opin Chem Eng       Date:  2015-02-01       Impact factor: 5.163

2.  Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.

Authors:  Jinxie Zhang; Wei Tao; Yuhan Chen; Danfeng Chang; Teng Wang; Xudong Zhang; Lin Mei; Xiaowei Zeng; Laiqiang Huang
Journal:  J Mater Sci Mater Med       Date:  2015-03-20       Impact factor: 3.896

Review 3.  Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy.

Authors:  David M Francis; Susan N Thomas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-25       Impact factor: 15.470

Review 4.  Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.

Authors:  Silvia Moreno-Mendieta; Daniel Guillén; Nathaly Vasquez-Martínez; Rogelio Hernández-Pando; Sergio Sánchez; Romina Rodríguez-Sanoja
Journal:  Pharm Res       Date:  2022-06-23       Impact factor: 4.580

Review 5.  Engineered nanomaterial exposure and the risk of allergic disease.

Authors:  Jonathan H Shannahan; Jared M Brown
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-04

6.  Contribution of engineered nanomaterials physicochemical properties to mast cell degranulation.

Authors:  Monica M Johnson; Ryan Mendoza; Achyut J Raghavendra; Ramakrishna Podila; Jared M Brown
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 7.  Translational nanoparticle engineering for cancer vaccines.

Authors:  Adam J Grippin; Elias J Sayour; Duane A Mitchell
Journal:  Oncoimmunology       Date:  2017-02-22       Impact factor: 8.110

Review 8.  Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy.

Authors:  Jianbo Jia; Yi Zhang; Yan Xin; Cuijuan Jiang; Bing Yan; Shumei Zhai
Journal:  Front Oncol       Date:  2018-09-25       Impact factor: 6.244

Review 9.  Recent Advances and Future Perspectives in Polymer-Based Nanovaccines.

Authors:  Natassa Pippa; Maria Gazouli; Stergios Pispas
Journal:  Vaccines (Basel)       Date:  2021-05-26

Review 10.  Protein Supramolecular Structures: From Self-Assembly to Nanovaccine Design.

Authors:  Ximena Zottig; Mélanie Côté-Cyr; Dominic Arpin; Denis Archambault; Steve Bourgault
Journal:  Nanomaterials (Basel)       Date:  2020-05-25       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.